Commitment to Action

Development and Production of Low-Cost Vaccines

Commitment by

Jn-International Medical Corporation

In 2006, the JN International Medical Corporation committed to help eliminate preventable infectious diseases through the development and production of low-cost vaccines and rapid diagnostic test kits. This project was designed to address the growing need for vaccines and diagnostics in developing countries, especially in West Africa and Southeast Asia. For example--at the time of this commitment--JN Medical recognized an increasing demand for meningococcal vaccines in developed countries, which unfortunately had created a shortage throughout Africa and Asia. JN was in a position to provide these low-cost, effective vaccines and diagnostics to the world's poorest populations.
At the time of its last report in April of 2009, JN Medical's vaccine division had supplied over 750,000 doses of vaccine for Polio, DTP+Hb, Hepatitis B, and two million doses of Meningitis vaccine to West Africa.

Share

Tabs

Overview
Summary

Commitment

Development and Production of Low-Cost Vaccines

Launched

2006

Est. Duration

3 Years

Estimated Total Value

$10,000,000

Region

Africa, Asia

Countries

BENIN, BURKINA FASO, COTE D'IVOIRE, INDIA, INDONESIA, NIGER, SAUDI ARABIA, TOGO, UNITED ARAB EMIRATES

Commitment by

Jn-International Medical Corporation

Partner(s) of the Commitment Maker(s)

Pharmaco, Ltd.